Significance of N-terminal pro-B-type natriuretic peptide levels in lung cancer

High blood levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) have been shown in various malignancies. In lung cancer, the importance of NT-proBNP is not clear. In this study, we aimed to investigate the significance of the correlation of NT-proBNP levels in lung cancer with tumor stage...

Full description

Saved in:
Bibliographic Details
Main Authors: Sinem İnan, Semra Bilaçeroğlu, Burcu Uludağ Artun
Format: Article
Language:English
Published: PAGEPress Publications 2025-01-01
Series:Monaldi Archives for Chest Disease
Subjects:
Online Access:https://www.monaldi-archives.org/macd/article/view/3174
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583955110428672
author Sinem İnan
Semra Bilaçeroğlu
Burcu Uludağ Artun
author_facet Sinem İnan
Semra Bilaçeroğlu
Burcu Uludağ Artun
author_sort Sinem İnan
collection DOAJ
description High blood levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) have been shown in various malignancies. In lung cancer, the importance of NT-proBNP is not clear. In this study, we aimed to investigate the significance of the correlation of NT-proBNP levels in lung cancer with tumor stage, tumor diameter, histopathology, and specific sites of mediastinal metastasis: lymphadenopathy; pericardial, cardiac, major vessel, other mediastinal organ or lymphatic involvement/invasion. A total of 105 lung cancer and 120 control patients (chronic obstructive lung disease, interstitial lung disease, pulmonary thromboembolism, and pneumonia; 30/subgroup) with measured NT-proBNP levels were included retrospectively. Demographics, comorbidities, and echocardiographic findings in all patients, as well as histologic subtype, diameter, stage, and radiologic and/or pathologic mediastinal involvement/invasion of the tumor to the mediastinum in patients with lung cancer, were studied with regards to blood NT-proBNP levels. When lung cancer and control groups were compared globally or as subgroups with comorbidities, NT-proBNP levels did not show meaningful differences. However, NT-proBNP levels were determined to be 249 pg/mL and 88 pg/mL in lung cancer (n=68) and control subgroups (n=58) without comorbidities, respectively (p=0.001). Among lung cancer patients without comorbidities and those with cardiac, pericardial, major vascular, or other mediastinal involvement/invasion (lymphadenopathy, lymphatic, or other organ invasion) (n=27), the NT-proBNP level was 303 pg/mL, whereas it was 166 pg/mL in those without these mediastinal invasions (n=41) (p=0.031). There is a need for much larger, randomized studies to obtain evidence for the potential role of NT-proBNP as a helpful diagnostic biomarker for lung cancer. Clinical suspicion of malignancy may be posed if high NT-proBNP levels cannot be explained by all other risk factors and disorders or diseases. Furthermore, pericardial, cardiac, major vessel, or other mediastinal invasion/involvement should be sought when high NT-proBNP levels are determined in lung cancer patients without any comorbidities or risk factors for high NT-proBNP levels.
format Article
id doaj-art-1dc4b945d20f4d4f938d168823612b15
institution Kabale University
issn 1122-0643
2532-5264
language English
publishDate 2025-01-01
publisher PAGEPress Publications
record_format Article
series Monaldi Archives for Chest Disease
spelling doaj-art-1dc4b945d20f4d4f938d168823612b152025-01-28T01:39:42ZengPAGEPress PublicationsMonaldi Archives for Chest Disease1122-06432532-52642025-01-0110.4081/monaldi.2025.3174Significance of N-terminal pro-B-type natriuretic peptide levels in lung cancerSinem İnan0https://orcid.org/0000-0001-9708-7488Semra Bilaçeroğlu1https://orcid.org/0000-0002-9703-9598Burcu Uludağ Artun2https://orcid.org/0000-0003-2178-6308Department of Allergy and Immunology, Izmir City Hospital, IzmirDepartment of Pulmonology, Izmir Faculty of Medicine, University of Health Sciences, IzmirDepartment of Cardiology, Izmir City Hospital, Izmir High blood levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) have been shown in various malignancies. In lung cancer, the importance of NT-proBNP is not clear. In this study, we aimed to investigate the significance of the correlation of NT-proBNP levels in lung cancer with tumor stage, tumor diameter, histopathology, and specific sites of mediastinal metastasis: lymphadenopathy; pericardial, cardiac, major vessel, other mediastinal organ or lymphatic involvement/invasion. A total of 105 lung cancer and 120 control patients (chronic obstructive lung disease, interstitial lung disease, pulmonary thromboembolism, and pneumonia; 30/subgroup) with measured NT-proBNP levels were included retrospectively. Demographics, comorbidities, and echocardiographic findings in all patients, as well as histologic subtype, diameter, stage, and radiologic and/or pathologic mediastinal involvement/invasion of the tumor to the mediastinum in patients with lung cancer, were studied with regards to blood NT-proBNP levels. When lung cancer and control groups were compared globally or as subgroups with comorbidities, NT-proBNP levels did not show meaningful differences. However, NT-proBNP levels were determined to be 249 pg/mL and 88 pg/mL in lung cancer (n=68) and control subgroups (n=58) without comorbidities, respectively (p=0.001). Among lung cancer patients without comorbidities and those with cardiac, pericardial, major vascular, or other mediastinal involvement/invasion (lymphadenopathy, lymphatic, or other organ invasion) (n=27), the NT-proBNP level was 303 pg/mL, whereas it was 166 pg/mL in those without these mediastinal invasions (n=41) (p=0.031). There is a need for much larger, randomized studies to obtain evidence for the potential role of NT-proBNP as a helpful diagnostic biomarker for lung cancer. Clinical suspicion of malignancy may be posed if high NT-proBNP levels cannot be explained by all other risk factors and disorders or diseases. Furthermore, pericardial, cardiac, major vessel, or other mediastinal invasion/involvement should be sought when high NT-proBNP levels are determined in lung cancer patients without any comorbidities or risk factors for high NT-proBNP levels. https://www.monaldi-archives.org/macd/article/view/3174Lung cancerN-terminal pro-brain natriuretic peptidemediastinal invasioncomorbiditytumor stagetumor histology
spellingShingle Sinem İnan
Semra Bilaçeroğlu
Burcu Uludağ Artun
Significance of N-terminal pro-B-type natriuretic peptide levels in lung cancer
Monaldi Archives for Chest Disease
Lung cancer
N-terminal pro-brain natriuretic peptide
mediastinal invasion
comorbidity
tumor stage
tumor histology
title Significance of N-terminal pro-B-type natriuretic peptide levels in lung cancer
title_full Significance of N-terminal pro-B-type natriuretic peptide levels in lung cancer
title_fullStr Significance of N-terminal pro-B-type natriuretic peptide levels in lung cancer
title_full_unstemmed Significance of N-terminal pro-B-type natriuretic peptide levels in lung cancer
title_short Significance of N-terminal pro-B-type natriuretic peptide levels in lung cancer
title_sort significance of n terminal pro b type natriuretic peptide levels in lung cancer
topic Lung cancer
N-terminal pro-brain natriuretic peptide
mediastinal invasion
comorbidity
tumor stage
tumor histology
url https://www.monaldi-archives.org/macd/article/view/3174
work_keys_str_mv AT sineminan significanceofnterminalprobtypenatriureticpeptidelevelsinlungcancer
AT semrabilaceroglu significanceofnterminalprobtypenatriureticpeptidelevelsinlungcancer
AT burcuuludagartun significanceofnterminalprobtypenatriureticpeptidelevelsinlungcancer